It was not clear why the putative major interacting region did not show a typical infection inhibition activity, although several possible reasons can be proposed—e.g., it may be that such peptides could not form the correct 3D structure and/or that the peptides were not long enough to inhibit the interaction between HBV and ATP5B and so on. The gene discussed is ATP5F1B; the disease is infection.